Journal of
eISSN: 2377-4282
Submit manuscript...
Review Article Volume 7 Issue 1
Participation in Clinical Research and Paradigms of Ethical Responsibilities
Kadour Ghanemi, Shuangsheng Yan
Received: January 01, 1971 | Published: January 5, 2018
Citation: Ghanemi K, Yan S (2018) Participation in Clinical Research and Paradigms of Ethical Responsibilities. J Nanomed Res 7(1): 00166. DOI: 10.15406/jnmr.2018.07.00166
Abstract
Nowadays the development and epidemics of different diseases drive biopharmaceutics to innovate and develop new therapeutic options due to the urgent need for new biodrugs to ensure the best health benefits for the populations. Through the last epoch, biopharmaceutical innovation had an effective role in improving the mankind health care as well as their life quality. Despite all the advantages and the relief which the biopharmaceutical innovation provides to the mankind health and its benefits, the biopharmaceutical innovation does not escape from a variety of bioethical challenges and moral principles governing the participation in clinical studies. Indeed, such ethical responsibilities are discussed both in the public and in the healthcare sectors.
Surveys in different countries have shown the necessity and the importance of the ethical techniques adherence. Among the ethical responsible criterions in the use of human tissue in the clinical researches is avoiding any kind of infringement of the patient’s rights, giving the participants a whole explanation about this research, respecting his privacy and autonomy also respecting his opinions, his freedom of choices and decisions towards the research for determining whether or not to recruit someone in the research represent high ethical standards that all the researchers need to respect. Moreover, taking into consideration the patients and the participants feelings and avoiding exploiting their weak position to urge and push them to participate and join the clinical research is a critical issue as well. In addition, the researchers and clinicians should make a therapeutic, financial and moral follow up and compensation to the participants in case of any research disadvantages. The main aim of any research team is to prevent any serious outcomes which can drive the life of the participant to danger.
Keywords: Clinical research, Ethics, Responsibility, Consent, Privacy, Biodrug, Innovation, Pharmacology, Compensation, Health Conditions, Marginalization, Research Efficacy, Human Dignity, Biopharmaceutical firms
©2018 Ghanemi, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.